Found: 142
Select item for more details and to access through your institution.
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: Is it necessary for all patients?
- Published in:
- Journal of Surgical Oncology, 2015, v. 111, n. 4, p. 439, doi. 10.1002/jso.23835
- By:
- Publication type:
- Article
The effect of postoperative pelvic irradiation after complete resection of metastatic rectal cancer.
- Published in:
- Journal of Surgical Oncology, 2012, v. 105, n. 3, p. 244, doi. 10.1002/jso.22109
- By:
- Publication type:
- Article
Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
- Published in:
- Xenotransplantation, 2006, v. 13, n. 4, p. 328, doi. 10.1111/j.1399-3089.2006.00311.x
- By:
- Publication type:
- Article
The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4556, doi. 10.3390/cancers14194556
- By:
- Publication type:
- Article
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1647, doi. 10.3390/cancers13071647
- By:
- Publication type:
- Article
Unique perception of clinical trials by Korean cancer patients.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2407-12-594
- By:
- Publication type:
- Article
Unique perception of clinical trials by Korean cancer patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-110
- By:
- Publication type:
- Article
Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
- Published in:
- Proteomics, 2012, v. 12, n. 23/24, p. 3590, doi. 10.1002/pmic.201200101
- By:
- Publication type:
- Article
Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models.
- Published in:
- Oncology, 2011, v. 80, n. 3/4, p. 167, doi. 10.1159/000327591
- By:
- Publication type:
- Article
A Prognostic Model to Predict Clinical Outcomes with First-Line Gemcitabine-Based Chemotherapy in Advanced Pancreatic Cancer.
- Published in:
- Oncology, 2011, v. 80, n. 3/4, p. 175, doi. 10.1159/000328449
- By:
- Publication type:
- Article
High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients.
- Published in:
- Oncology, 2011, v. 80, n. 3/4, p. 257, doi. 10.1159/000328795
- By:
- Publication type:
- Article
Analysis of Prognostic Factors of Pediatric-Type Sarcomas in Adult Patients.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 21, doi. 10.1159/000327222
- By:
- Publication type:
- Article
A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 326, doi. 10.1159/000209384
- By:
- Publication type:
- Article
Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases.
- Published in:
- Oncology, 2007, v. 73, n. 3/4, p. 192, doi. 10.1159/000127386
- By:
- Publication type:
- Article
Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer.
- Published in:
- Oncology, 2004, v. 66, n. 1, p. 32, doi. 10.1159/000076332
- By:
- Publication type:
- Article
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1532, doi. 10.1038/mt.2015.109
- By:
- Publication type:
- Article
Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 155, doi. 10.1634/theoncologist.2017-0528
- By:
- Publication type:
- Article
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1169, doi. 10.1634/theoncologist.2017-0020
- By:
- Publication type:
- Article
Nematicidal Activity of Benzyloxyalkanols against Pine Wood Nematode.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 3, p. 384, doi. 10.3390/biom11030384
- By:
- Publication type:
- Article
Multi‐biomarker panel prediction model for diagnosis of pancreatic cancer.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 1, p. 122, doi. 10.1002/jhbp.986
- By:
- Publication type:
- Article
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4659062
- By:
- Publication type:
- Article
The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231170484
- By:
- Publication type:
- Article
The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231170484
- By:
- Publication type:
- Article
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221117638
- By:
- Publication type:
- Article
Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 11, p. 2828, doi. 10.1002/cncr.26614
- By:
- Publication type:
- Article
Extraosseous osteosarcoma: Single institutional experience in Korea.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2010, v. 6, n. 2, p. 126, doi. 10.1111/j.1743-7563.2010.01278.x
- By:
- Publication type:
- Article
Clinical outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision in locally advanced rectal cancer with mesorectal fascia involvement.
- Published in:
- Radiation Oncology Journal, 2024, v. 42, n. 2, p. 130, doi. 10.3857/roj.2023.01032
- By:
- Publication type:
- Article
Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 217, doi. 10.3857/roj.2017.00269
- By:
- Publication type:
- Article
Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer.
- Published in:
- Radiation Oncology Journal, 2016, v. 34, n. 1, p. 34, doi. 10.3857/roj.2016.34.1.34
- By:
- Publication type:
- Article
Can we omit prophylactic inguinal nodal irradiation in anal cancer patients?
- Published in:
- Radiation Oncology Journal, 2015, v. 33, n. 2, p. 83, doi. 10.3857/roj.2015.33.2.83
- By:
- Publication type:
- Article
Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases.
- Published in:
- Radiation Oncology Journal, 2014, v. 32, n. 2, p. 77, doi. 10.3857/roj.2014.32.2.77
- By:
- Publication type:
- Article
Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer.
- Published in:
- Radiation Oncology Journal, 2012, v. 30, n. 3, p. 117, doi. 10.3857/roj.2012.30.3.117
- By:
- Publication type:
- Article
Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 2, p. 1, doi. 10.1038/s41419-023-05630-5
- By:
- Publication type:
- Article
The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 225, doi. 10.2147/OTT.S187621
- By:
- Publication type:
- Article
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920965842
- By:
- Publication type:
- Article
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 1, p. 499, doi. 10.21873/invivo.12284
- By:
- Publication type:
- Article
Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 8, p. 674, doi. 10.1093/jnci/djr070
- By:
- Publication type:
- Article
Prevalence of RAF1 Aberrations in Metastatic Cancer Patients: Real-World Data.
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3264, doi. 10.3390/biomedicines11123264
- By:
- Publication type:
- Article
Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 4, p. e382, doi. 10.5301/jbm.5000151
- By:
- Publication type:
- Article
RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55767-7
- By:
- Publication type:
- Article
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51981-5
- By:
- Publication type:
- Article